ACRV · Acrivon Therapeutics, Inc.

$2.06 -0.09 (-4.19%) At close · Aug 28

Market Cap

$89.13M

42.85M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Blume-Jensen	M.D., Ph.D. Chief Executive Officer, President and Director	$709,893	—	—	$1,592,245	$410,400	$6,000	$2,718,538
Kristina Masson	Ph.D, M.B.A. Executive Vice President, Business Operations, Director	$594,472	—	—	$573,206	$251,248	$6,000	$1,424,926
Eric Devroe	Chief Operating Officer	$528,745	—	—	$573,206	$250,052	$6,000	$1,358,003

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Blume-Jensen	M.D., Ph.D. Chief Executive Officer, President and Director	$655,133	—	—	$931,760	$413,419	—	$2,000,312
Kristina Masson	M.B.A., Ph.D. Executive Vice President, Business Operations, Director	$565,539	—	—	$372,702	$258,935	—	$1,197,176
Eric Devroe	Chief Operating Officer	$510,467	—	—	$372,702	$263,559	—	$1,146,728

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Blume-Jensen	M.D., Ph.D. Chief Executive Officer, President and Director	$629,000	—	$5,488,273	$348,700	—	—	$6,465,973
Kristina Masson	M.B.A., Ph.D. Executive Vice President, Business Operations, Director	$521,383	—	—	$218,400	—	—	$739,783
Eric Devroe	Chief Operating Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Blume-Jensen	M.D., Ph.D. Chief Executive Officer, President and Director	$535,942	—	$18,728,000	$1,951,598	$469,700	—	$21,685,240
Eric Devroe	Chief Operating Officer	$386,779	—	$417,288	$1,147,830	$228,000	—	$2,179,897
Rasmus Holm-Jorgensen	Chief Financial Officer	$288,231	—	$250,375	$1,045,702	$136,600	—	$1,720,908
Kristina Masson	M.B.A., Ph.D. Executive Vice President, Business Operations, Director	—	—	—	—	—	—	—
Mary-Alice Miller	Chief Legal Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Blume-Jensen	M.D., Ph.D. Chief Executive Officer, President and Director	$430,000	—	—	$111,771	$215,000	—	$756,771
Eric Devroe	Chief Operating Officer	$300,000	—	—	$87,939	$75,000	—	$462,939

Executive changes

Person	Role	Change	Effective	Filed
Charles Baum, M.D., Ph.D.	Class I Director	Appointed	2026-06-17	2026-06-17
Michael Tomsicek, M.B.A.	Class I Director	Appointed	2026-06-17	2026-06-17
Adam Levy, Ph.D., M.B.A.	Chief Financial Officer	Appointed	2025-04-01	2025-03-14
Santhosh Palani, Ph.D., CFA	director	Appointed	2024-03-04	2024-03-04
Ivana Magovcevic-Liebisch, Ph.D., J.D.	director	Appointed	2024-02-08	2024-02-08

Key facts CIK 1781174 CUSIP 004890109 13F (30d) 44 filings 44 filers Visit website Investor relations